Industry Research Reports
Home > Reports > Chemical & Material > Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Outlook, In‑Depth Analysis & Forecast to 2031
Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-08-05
Pages: 154 Pages
Report ld: 4872261
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
PDF Download
- Description
- Table of Contents
- Table of Figures
- PDF Download
The global 2'-F-Phosphoramidites for Oligonucleotide Synthesis market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
RNA oligonucleotides synthesized with 2'-fluorinated Bz A, iBu G, Ac C, and U phosphoramidite showed enhanced body thermal stability of RNA double-stranded and nuclease resistance of single-stranded RNA. These phosphorimides were incorporated into custom siRNA oligonucleotides for gene targeting and inhibition studies.
From a downstream perspective, Biotechnology Companies accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
2'-F-Phosphoramidites for Oligonucleotide Synthesis leading manufacturers including Glen Research, ChemGenes, Bioneer, Thermo Fisher Scientific, Merck, BOC Sciences, TCI, Hongene Biotech, Biosynth Carbosynth, BLD Pharmatech, etc., dominate supply; the top five capture approximately % of global revenue, with Glen Research leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global 2'-F-Phosphoramidites for Oligonucleotide Synthesis market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Glen Research
- ChemGenes
- Bioneer
- Thermo Fisher Scientific
- Merck
- BOC Sciences
- TCI
- Hongene Biotech
- Biosynth Carbosynth
- BLD Pharmatech
- LGC Standards
- Chemtour
- Wuhu Huaren Science and Technology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 2'-F-dA(Bz) Phosphoramidite
- 2'-F-dC(Ac) Phosphoramidite
- 2'-F-dG(ibu) Phosphoramidite
- Others
Segment by Application
- Biotechnology Companies
- Research Laboratories
CHAPTER OUTLINE
Chapter 1: Defines the 2'-F-Phosphoramidites for Oligonucleotide Synthesis study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to 2'-F-Phosphoramidites for Oligonucleotide Synthesis: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 2'-F-dA(Bz) Phosphoramidite
1.2.3 2'-F-dC(Ac) Phosphoramidite
1.2.4 2'-F-dG(ibu) Phosphoramidite
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biotechnology Companies
1.3.3 Research Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Estimates and Forecasts 2020-2031
2.2 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Estimates and Forecasts 2020-2031
2.4 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 2'-F-dA(Bz) Phosphoramidite Market Size by Manufacturers
4.5.2 2'-F-dC(Ac) Phosphoramidite Market Size by Manufacturers
4.5.3 2'-F-dG(ibu) Phosphoramidite Market Size by Manufacturers
4.5.4 Others Market Size by Manufacturers
4.6 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales and Revenue by Type (2020-2031)
7.4 North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales and Revenue by Type (2020-2031)
8.4 Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales and Revenue by Type (2020-2031)
10.4 Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Glen Research
12.1.1 Glen Research Corporation Information
12.1.2 Glen Research Business Overview
12.1.3 Glen Research 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.1.4 Glen Research 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Glen Research 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Product in 2024
12.1.6 Glen Research 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Application in 2024
12.1.7 Glen Research 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Geographic Area in 2024
12.1.8 Glen Research 2'-F-Phosphoramidites for Oligonucleotide Synthesis SWOT Analysis
12.1.9 Glen Research Recent Developments
12.2 ChemGenes
12.2.1 ChemGenes Corporation Information
12.2.2 ChemGenes Business Overview
12.2.3 ChemGenes 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.2.4 ChemGenes 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 ChemGenes 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Product in 2024
12.2.6 ChemGenes 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Application in 2024
12.2.7 ChemGenes 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Geographic Area in 2024
12.2.8 ChemGenes 2'-F-Phosphoramidites for Oligonucleotide Synthesis SWOT Analysis
12.2.9 ChemGenes Recent Developments
12.3 Bioneer
12.3.1 Bioneer Corporation Information
12.3.2 Bioneer Business Overview
12.3.3 Bioneer 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.3.4 Bioneer 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Bioneer 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Product in 2024
12.3.6 Bioneer 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Application in 2024
12.3.7 Bioneer 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Geographic Area in 2024
12.3.8 Bioneer 2'-F-Phosphoramidites for Oligonucleotide Synthesis SWOT Analysis
12.3.9 Bioneer Recent Developments
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Corporation Information
12.4.2 Thermo Fisher Scientific Business Overview
12.4.3 Thermo Fisher Scientific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.4.4 Thermo Fisher Scientific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Thermo Fisher Scientific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Product in 2024
12.4.6 Thermo Fisher Scientific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Application in 2024
12.4.7 Thermo Fisher Scientific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Geographic Area in 2024
12.4.8 Thermo Fisher Scientific 2'-F-Phosphoramidites for Oligonucleotide Synthesis SWOT Analysis
12.4.9 Thermo Fisher Scientific Recent Developments
12.5 Merck
12.5.1 Merck Corporation Information
12.5.2 Merck Business Overview
12.5.3 Merck 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.5.4 Merck 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Merck 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Product in 2024
12.5.6 Merck 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Application in 2024
12.5.7 Merck 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Geographic Area in 2024
12.5.8 Merck 2'-F-Phosphoramidites for Oligonucleotide Synthesis SWOT Analysis
12.5.9 Merck Recent Developments
12.6 BOC Sciences
12.6.1 BOC Sciences Corporation Information
12.6.2 BOC Sciences Business Overview
12.6.3 BOC Sciences 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.6.4 BOC Sciences 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 BOC Sciences Recent Developments
12.7 TCI
12.7.1 TCI Corporation Information
12.7.2 TCI Business Overview
12.7.3 TCI 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.7.4 TCI 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 TCI Recent Developments
12.8 Hongene Biotech
12.8.1 Hongene Biotech Corporation Information
12.8.2 Hongene Biotech Business Overview
12.8.3 Hongene Biotech 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.8.4 Hongene Biotech 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Hongene Biotech Recent Developments
12.9 Biosynth Carbosynth
12.9.1 Biosynth Carbosynth Corporation Information
12.9.2 Biosynth Carbosynth Business Overview
12.9.3 Biosynth Carbosynth 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.9.4 Biosynth Carbosynth 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Biosynth Carbosynth Recent Developments
12.10 BLD Pharmatech
12.10.1 BLD Pharmatech Corporation Information
12.10.2 BLD Pharmatech Business Overview
12.10.3 BLD Pharmatech 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.10.4 BLD Pharmatech 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 BLD Pharmatech Recent Developments
12.11 LGC Standards
12.11.1 LGC Standards Corporation Information
12.11.2 LGC Standards Business Overview
12.11.3 LGC Standards 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.11.4 LGC Standards 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 LGC Standards Recent Developments
12.12 Chemtour
12.12.1 Chemtour Corporation Information
12.12.2 Chemtour Business Overview
12.12.3 Chemtour 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.12.4 Chemtour 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Chemtour Recent Developments
12.13 Wuhu Huaren Science and Technology
12.13.1 Wuhu Huaren Science and Technology Corporation Information
12.13.2 Wuhu Huaren Science and Technology Business Overview
12.13.3 Wuhu Huaren Science and Technology 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Models, Descriptions and Specifications
12.13.4 Wuhu Huaren Science and Technology 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Wuhu Huaren Science and Technology Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 2'-F-Phosphoramidites for Oligonucleotide Synthesis Industry Chain
13.2 2'-F-Phosphoramidites for Oligonucleotide Synthesis Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 2'-F-Phosphoramidites for Oligonucleotide Synthesis Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Region (2020-2025) & (Tons)
Table 8. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production by Region (2020-2025) & (Tons)
Table 12. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production by Region (2026-2031) & (Tons)
Table 13. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Share by Manufacturers (2020-2025)
Table 15. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 2'-F-Phosphoramidites for Oligonucleotide Synthesis as of 2024)
Table 19. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
Table 21. Key Manufacturers 2'-F-Phosphoramidites for Oligonucleotide Synthesis Manufacturing Base and Headquarters
Table 22. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Type (2020-2025) & (Tons)
Table 26. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Type (2026-2031) & (Tons)
Table 27. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis ASP by Type (2020-2031) & (US$/kg)
Table 30. Technical Specifications by Key Product Type
Table 31. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Application (2020-2025) & (Tons)
Table 32. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales by Application (2026-2031) & (Tons)
Table 33. 2'-F-Phosphoramidites for Oligonucleotide Synthesis High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis ASP by Application (2020-2031) & (US$/kg)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Growth Accelerators and Market Barriers
Table 40. North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Growth Accelerators and Market Barriers
Table 43. Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Growth Accelerators and Market Barriers
Table 48. Southeast Asia 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Investment Opportunities and Key Challenges
Table 50. Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Investment Opportunities and Key Challenges
Table 52. Middle East and Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Glen Research Corporation Information
Table 54. Glen Research Description and Major Businesses
Table 55. Glen Research Product Models, Descriptions and Specifications
Table 56. Glen Research Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 57. Glen Research Sales Value Proportion by Product in 2024
Table 58. Glen Research Sales Value Proportion by Application in 2024
Table 59. Glen Research Sales Value Proportion by Geographic Area in 2024
Table 60. Glen Research 2'-F-Phosphoramidites for Oligonucleotide Synthesis SWOT Analysis
Table 61. Glen Research Recent Developments
Table 62. ChemGenes Corporation Information
Table 63. ChemGenes Description and Major Businesses
Table 64. ChemGenes Product Models, Descriptions and Specifications
Table 65. ChemGenes Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 66. ChemGenes Sales Value Proportion by Product in 2024
Table 67. ChemGenes Sales Value Proportion by Application in 2024
Table 68. ChemGenes Sales Value Proportion by Geographic Area in 2024
Table 69. ChemGenes 2'-F-Phosphoramidites for Oligonucleotide Synthesis SWOT Analysis
Table 70. ChemGenes Recent Developments
Table 71. Bioneer Corporation Information
Table 72. Bioneer Description and Major Businesses
Table 73. Bioneer Product Models, Descriptions and Specifications
Table 74. Bioneer Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. Bioneer Sales Value Proportion by Product in 2024
Table 76. Bioneer Sales Value Proportion by Application in 2024
Table 77. Bioneer Sales Value Proportion by Geographic Area in 2024
Table 78. Bioneer 2'-F-Phosphoramidites for Oligonucleotide Synthesis SWOT Analysis
Table 79. Bioneer Recent Developments
Table 80. Thermo Fisher Scientific Corporation Information
Table 81. Thermo Fisher Scientific Description and Major Businesses
Table 82. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 83. Thermo Fisher Scientific Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 84. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 85. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 86. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 87. Thermo Fisher Scientific 2'-F-Phosphoramidites for Oligonucleotide Synthesis SWOT Analysis
Table 88. Thermo Fisher Scientific Recent Developments
Table 89. Merck Corporation Information
Table 90. Merck Description and Major Businesses
Table 91. Merck Product Models, Descriptions and Specifications
Table 92. Merck Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 93. Merck Sales Value Proportion by Product in 2024
Table 94. Merck Sales Value Proportion by Application in 2024
Table 95. Merck Sales Value Proportion by Geographic Area in 2024
Table 96. Merck 2'-F-Phosphoramidites for Oligonucleotide Synthesis SWOT Analysis
Table 97. Merck Recent Developments
Table 98. BOC Sciences Corporation Information
Table 99. BOC Sciences Description and Major Businesses
Table 100. BOC Sciences Product Models, Descriptions and Specifications
Table 101. BOC Sciences Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 102. BOC Sciences Recent Developments
Table 103. TCI Corporation Information
Table 104. TCI Description and Major Businesses
Table 105. TCI Product Models, Descriptions and Specifications
Table 106. TCI Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 107. TCI Recent Developments
Table 108. Hongene Biotech Corporation Information
Table 109. Hongene Biotech Description and Major Businesses
Table 110. Hongene Biotech Product Models, Descriptions and Specifications
Table 111. Hongene Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 112. Hongene Biotech Recent Developments
Table 113. Biosynth Carbosynth Corporation Information
Table 114. Biosynth Carbosynth Description and Major Businesses
Table 115. Biosynth Carbosynth Product Models, Descriptions and Specifications
Table 116. Biosynth Carbosynth Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 117. Biosynth Carbosynth Recent Developments
Table 118. BLD Pharmatech Corporation Information
Table 119. BLD Pharmatech Description and Major Businesses
Table 120. BLD Pharmatech Product Models, Descriptions and Specifications
Table 121. BLD Pharmatech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 122. BLD Pharmatech Recent Developments
Table 123. LGC Standards Corporation Information
Table 124. LGC Standards Description and Major Businesses
Table 125. LGC Standards Product Models, Descriptions and Specifications
Table 126. LGC Standards Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 127. LGC Standards Recent Developments
Table 128. Chemtour Corporation Information
Table 129. Chemtour Description and Major Businesses
Table 130. Chemtour Product Models, Descriptions and Specifications
Table 131. Chemtour Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 132. Chemtour Recent Developments
Table 133. Wuhu Huaren Science and Technology Corporation Information
Table 134. Wuhu Huaren Science and Technology Description and Major Businesses
Table 135. Wuhu Huaren Science and Technology Product Models, Descriptions and Specifications
Table 136. Wuhu Huaren Science and Technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 137. Wuhu Huaren Science and Technology Recent Developments
Table 138. Key Raw Materials Distribution
Table 139. Raw Materials Key Suppliers
Table 140. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 141. Milestones in Production Technology Evolution
Table 142. Distributors List
Table 143. Market Trends and Market Evolution
Table 144. Market Drivers and Opportunities
Table 145. Market Challenges, Risks, and Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. 2'-F-Phosphoramidites for Oligonucleotide Synthesis Product Picture
Figure 2. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 2'-F-dA(Bz) Phosphoramidite Product Picture
Figure 4. 2'-F-dC(Ac) Phosphoramidite Product Picture
Figure 5. 2'-F-dG(ibu) Phosphoramidite Product Picture
Figure 6. Others Product Picture
Figure 7. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Biotechnology Companies
Figure 9. Research Laboratories
Figure 10. 2'-F-Phosphoramidites for Oligonucleotide Synthesis Report Years Considered
Figure 11. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 13. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Market Share by Region (2020-2031)
Figure 15. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales (2020-2031) & (Tons)
Figure 16. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Market Share by Region (2020-2031)
Figure 18. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 19. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production Trend by Region (2020-2031) (Tons)
Figure 20. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production Growth Rate in North America (2020-2031) & (Tons)
Figure 23. 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 24. 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production Growth Rate in China (2020-2031) & (Tons)
Figure 25. 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 26. Top 5 and Top 10 Manufacturers 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume Market Share in 2024
Figure 27. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. 2'-F-dA(Bz) Phosphoramidite Revenue Market Share by Manufacturer in 2024
Figure 30. 2'-F-dC(Ac) Phosphoramidite Revenue Market Share by Manufacturer in 2024
Figure 31. 2'-F-dG(ibu) Phosphoramidite Revenue Market Share by Manufacturer in 2024
Figure 32. Others Revenue Market Share by Manufacturer in 2024
Figure 33. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 34. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 35. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Market Share by Type (2020-2031)
Figure 36. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Market Share by Type (2020-2031)
Figure 37. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Market Share by Application (2020-2031)
Figure 38. Global 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue Market Share by Application (2020-2031)
Figure 39. North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales YoY (2020-2031) & (Tons)
Figure 40. North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue YoY (2020-2031) & (US$ Million)
Figure 41. North America Top 5 Manufacturers 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) in 2024
Figure 42. North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume (Tons) by Type (2020- 2031)
Figure 43. North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 44. North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume (Tons) by Application (2020-2031)
Figure 45. North America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. US 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 47. Canada 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 48. Mexico 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 49. Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales YoY (2020-2031) & (Tons)
Figure 50. Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Europe Top 5 Manufacturers 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) in 2024
Figure 52. Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume (Tons) by Type (2020-2031)
Figure 53. Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) by Type (2020-2031)
Figure 54. Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume (Tons) by Application (2020-2031)
Figure 55. Europe 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Germany 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 57. France 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 58. U.K. 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 59. Italy 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 60. Russia 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales YoY (2020-2031) & (Tons)
Figure 62. Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Asia-Pacific Top 8 Manufacturers 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) in 2024
Figure 64. Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume (Tons) by Type (2020- 2031)
Figure 65. Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 66. Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume (Tons) by Application (2020-2031)
Figure 67. Asia-Pacific 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Indonesia 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 69. Japan 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 70. South Korea 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 71. China Taiwan 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 72. India 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2031) & (US$ Million)
Figure 73. Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales YoY (2020-2031) & (Tons)
Figure 74. Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Central and South America Top 5 Manufacturers 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) in 2024
Figure 76. Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume (Tons) by Type (2021-2031)
Figure 77. Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume (Tons) by Application (2020-2031)
Figure 79. Central and South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. Brazil 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2025) & (US$ Million)
Figure 81. Argentina 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2025) & (US$ Million)
Figure 82. Middle East, and Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales YoY (2020-2031) & (Tons)
Figure 83. Middle East and Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue YoY (2020-2031) & (US$ Million)
Figure 84. Middle East and Africa Top 5 Manufacturers 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) in 2024
Figure 85. Middle East and Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume (Tons) by Type (2021-2031)
Figure 86. South America 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) by Type (2020-2031)
Figure 87. Middle East and Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Volume (Tons) by Application (2020-2031)
Figure 88. Middle East and Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 89. GCC Countries 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2025) & (US$ Million)
Figure 90. Turkey 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2025) & (US$ Million)
Figure 91. Egypt 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2025) & (US$ Million)
Figure 92. South Africa 2'-F-Phosphoramidites for Oligonucleotide Synthesis Revenue (2020-2025) & (US$ Million)
Figure 93. 2'-F-Phosphoramidites for Oligonucleotide Synthesis Industry Chain Mapping
Figure 94. Regional 2'-F-Phosphoramidites for Oligonucleotide Synthesis Manufacturing Base Distribution (%)
Figure 95. 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production Process
Figure 96. Regional 2'-F-Phosphoramidites for Oligonucleotide Synthesis Production Cost Structure
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global 2'-F-Phosphoramidites for Oligonucleotide Synthesis market?
The top companies in the global 2'-F-Phosphoramidites for Oligonucleotide Synthesis market are Glen Research、ChemGenes、Bioneer.
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now